Cooperation of Epac1/Rap1/Akt and PKA in prostaglandin E 2-induced proliferation of human umbilical cord blood derived mesenchymal stem cells: Involvement of c-Myc and VEGF expression

Journal of Cellular Physiology

Volumn 227, Issue 12, 2012, Pages 3756-3767

  Jang, Min Woo ^a   Yun, Seung Pil ^a   Park, Jae Hong ^a   Ryu, Jung Min ^a   Lee, Jang Hern ^b   Han, Ho Jae ^b  

^a Chonnam National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CYCLIC AMP; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MYC PROTEIN; PROSTAGLANDIN E2; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; RAP1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; FETAL BLOOD; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MESENCHYMAL STEM CELLS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TELOMERE-BINDING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865408431     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24084     Document Type: Article

References (42)

1. Aronoff DM, Canetti C, Serezani CH, Luo M, Peters-Golden M. 2005. Cutting edge: Macrophage inhibition by cyclic AMP (cAMP): Differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol 174: 595-599.
2. Baek SH, Kioussi C, Briata P, Wang D, Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris A, Rose DW, Rosenfeld MG. 2003. Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc Natl Acad Sci USA 100: 3245-3250.
3. Bieback K, Kern S, Kluter H, Eichler H. 2004. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 625-634.
4. Bos JL. 2003. Epac: A new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol 4: 733-738.
5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Brennesvik EO, Ktori C, Ruzzin J, Jebens E, Shepherd PR, Jensen J. 2005. Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: Implications for cross talk between insulin and adrenaline. Cell Signal 17: 1551-1559.
7. Brett CM, Washington CB, Ott RJ, Gutierrez MM, Giacomini KM. 1993. Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush border membrane vesicles from human kidney. Pharm Res 10: 423-426.
8. Chang CW, Chang GD, Chen H. 2011. A novel cyclic AMP/Epac1/CaMKI signaling cascade promotes GCM1 desumoylation and placental cell fusion. Mol Cell Biol 31: 3820-3831.
9. Cheng X, Ji Z, Tsalkova T, Mei F. 2008. Epac and PKA: A tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai) 40: 651-662.
10. Cutler AJ, Limbani V, Girdlestone J, Navarrete CV. 2010. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol 185: 6617-6623.
11. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477.
12. de Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL. 2000. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275: 20829-20836.
13. 2 regulation of hematopoiesis and hematopoietic stem cell engraftment. Curr Opin Hematol 17: 308-312.
14. Gloerich M, Ponsioen B, Vliem MJ, Zhang Z, Zhao J, Kooistra MR, Price LS, Ritsma L, Zwartkruis FJ, Rehmann H, Jalink K, Bos JL. 2010. Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. Mol Cell Biol 30: 5421-5431.
15. 2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136: 1136-1147.
16. Haag S, Warnken M, Juergens UR, Racke K. 2008. Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 378: 617-630.
17. Hochbaum D, Hong K, Barila G, Ribeiro-Neto F, Altschuler DL. 2008. Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis. J Biol Chem 283: 4464-4468.
18. 2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113: 5444-5455.
19. 2A signaling module controls cAMP-dependent Akt regulation. J Biol Chem 283: 23129-23138.
20. Jiménez P, Piazuelo E, Cebrian C, Ortego J, Strunk M, Garcia-Gonzalez MA, Santander S, Alcedo J, Lanas A. 2010. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma. Aliment Pharmacol Ther 31: 440-451.
21. Kiermayer S, Biondi RM, Imig J, Plotz G, Haupenthal J, Zeuzem S, Piiper A. 2005. Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells. Mol Biol Cell 16: 5639-5648.
22. 2 through differential activation of cAMP-dependent protein kinase isoforms. Exp Cell Res 314: 1831-1838.
23. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675.
24. Li W, Jin B, Cornelius LA, Zhou B, Fu X, Shang D, Zheng H. 2011. Inhibitory effects of Rap1GAP overexpression on proliferation and migration of endothelial cells via ERK and Akt pathways. J Huazhong Univ Sci Technolog Med Sci 31: 721-727.
25. Malgieri A, Kantzari E, Patrizi MP, Gambardella S. 2010. Bone marrow and umbilical cord blood human mesenchymal stem cells: State of the art. Int J Clin Exp Med 3: 248-269.
26. Mani M, Carrasco DE, Zhang Y, Takada K, Gatt ME, Dutta-Simmons J, Ikeda H, Diaz-Griffero F, Pena-Cruz V, Bertagnolli M, Myeroff LL, Markowitz SD, Anderson KC, Carrasco DR. 2009. BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res 69: 7577-7586.
27. Michael LF, Asahara H, Shulman AI, Kraus WL, Montminy M. 2000. The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism. Mol Cell Biol 20: 1596-1603.
28. Misra UK, Pizzo SV. 2005. Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: Effects of silencing CREB gene expression on Akt activation. J Biol Chem 280: 38276-38289.
29. Murray AJ, Tucker SJ, Shewan DA. 2009. cAMP-dependent axon guidance is distinctly regulated by Epac and protein kinase A. J Neurosci 29: 15434-15444.
30. Regan JW. 2003. EP2 and EP4 prostanoid receptor signaling. Life Sci 74: 143-153.
31. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X, Bertherat J. 2002. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann NY Acad Sci 968: 65-74.
32. Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. 2010. Mesenchymal stem cells for clinical application. Vox Sang 98: 93-107.
33. Sugimoto Y, Narumiya S. 2007. Prostaglandin E receptors. J Biol Chem 282: 11613-11617.
34. Tapiero H, Ba GN, Couvreur P, Tew KD. 2002. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 56: 215-222.
35. Torii K, Nishizawa K, Kawasaki A, Yamashita Y, Katada M, Ito M, Nishimoto I, Terashita K, Aiso S, Matsuoka M. 2008. Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways. Cell Signal 20: 1256-1266.
36. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. 2002. Wnt signaling controls the phosphorylation status of β-catenin. J Biol Chem 277: 17901-17905.
37. von Bonin M, Kiani A, Platzbecker U, Schetelig J, Hölig K, Oelschlägel U, Thiede C, Ehninger G, Bornhauser M. 2009. Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation. Leuk Res 33: e215-e217.
38. 2 regulation of interleukin-1β expression in Leydig cell progenitors. Endocrinology 144: 1284-1291.
39. Wang H, Zhou H, Zou Y, Liu Q, Guo C, Gao G, Shao C, Gong Y. 2010. Resveratrol modulates angiogenesis through the GSK3β/β-catenin/TCF-dependent pathway in human endothelial cells. Biochem Pharmacol 80: 1386-1395.
40. Yan W, Tai HH. 2006. Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation, and cell morphology change following stimulation of thromboxane receptor alpha. J Pharmacol Exp Ther 317: 267-274.
41. Cip1/Waf1 enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells. Aging Cell 10: 349-361.
42. Yun SP, Lee MY, Ryu JM, Song CH, Han HJ. 2009. Role of HIF-1α and VEGF in human mesenchymal stem cell proliferation by 17β-estradiol: Involvement of PKC, PI3K/Akt, and MAPKs. Am J Physiol Cell Physiol 296: C317-326.